Publications by authors named "K Fukutani"

Artificial molecular machines, especially when based on wheel-and-axle complexes, can generate mechanical motions in response to external stimuli. Ferrocene (Fc) is a key component, but it decomposes at 300 K on metal surfaces. Here, a novel method is presented to construct and control the molecular complex composed of ammonium-linked ferrocene (Fc-amm) and tetrabrominated crown ether (BrCR) on a Cu(111) surface.

View Article and Find Full Text PDF

Hydrogen, the smallest and lightest element, readily permeates a variety of materials and modulates their physical properties. Identification of the hydrogen lattice location and its amount in crystals is key to understanding and controlling the hydrogen-induced properties. Combining nuclear reaction analysis (NRA) with the ion channeling technique, we experimentally determined the locations of H and D in epitaxial nanofilms of titanium hydrides from the analysis of the two-dimensional angular mappings of NRA yields.

View Article and Find Full Text PDF

We investigate ultrahigh concentration doping of hydrogen (H) into rutile-TiO (100) single crystals by low-energy (2.5 keV) hydrogen ion beam irradiation at low temperature (LT). While the hydrogen concentration was limited to HTiO at 300 K, nuclear reaction analysis (NRA) revealed ultrahigh concentration doping of hydrogen up to HTiO by the LT irradiation at 50 K.

View Article and Find Full Text PDF

The combination of elexacaftor/tezacaftor/ivacaftor (ETI, Trikafta) reverses the primary defect in cystic fibrosis (CF) by improving CFTR-mediated Cl and HCO secretion by airway epithelial cells (AECs), leading to improved lung function and less frequent exacerbations and hospitalizations. However, studies have shown that CFTR modulators like ivacaftor, a component of ETI, have numerous effects on CF cells beyond improved CFTR channel function. Because little is known about the effect of ETI on CF AEC gene expression, we exposed primary human AEC to ETI for 48 h and interrogated the transcriptome by RNA-seq and qPCR.

View Article and Find Full Text PDF

Unlabelled: The combination of elexacaftor/tezacaftor/ivacaftor (ETI, Trikafta) reverses the primary defect in Cystic Fibrosis (CF) by improving CFTR mediated Cl and HCO secretion by airway epithelial cells (AEC), leading to improved lung function and less frequent exacerbations and hospitalizations. However, studies have shown that CFTR modulators like ivacaftor, a component of ETI, has numerous effects on CF cells beyond improved CFTR channel function. Because little is known about the effect of ETI on CF AEC gene expression we exposed primary human AEC to ETI for 48 hours and interrogated the transcriptome by RNA-seq and qPCR.

View Article and Find Full Text PDF